During the past decade, Medical University of South Carolina, Site #148 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Medical University of South Carolina, Site #148" are "Chronic Myeloid Leukemia" (1 trials), "Chronic Myeloid Leukemia (CML)" (1 trials) and "Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)" (1 trials). Many other conditions were trialed in "Medical University of South Carolina, Site #148" in a lesser frequency.

Most popular intervention types in "Medical University of South Carolina, Site #148" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ponatinib" (2 trials) and "imatinib (Gleevec/ Glivec)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical University of South Carolina, Site #148" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Medical University of South Carolina, Site #148". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Medical University of South Carolina, Site #148, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medical University of South Carolina, Site #148, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".